Growth hormone and heart failure: Oxidative stress and energetic metabolism in rats

被引:25
作者
Seiva, F. R. F. [3 ]
Ebaid, G. M. X. [3 ]
Castro, A. V. B. [3 ]
Okoshi, K. [3 ]
Nascimento, A. [3 ]
Rocha, K. K. H. [1 ]
Padovani, C. R. [2 ]
Cicogna, A. C. [2 ]
Novelli, E. L. B. [1 ]
机构
[1] Sao Paulo State Univ, UNESP, Inst Biol Sci, Dept Chem & Biochem, BR-18618000 Sao Paulo, Brazil
[2] Sao Paulo State Univ, UNESP, Inst Biol Sci, Dept Stat, BR-18618000 Sao Paulo, Brazil
[3] Sao Paulo State Univ, UNESP, Sch Med, Dept Clin & Cardiol,Postgraduat Course, BR-18618000 Sao Paulo, Brazil
关键词
growth hormone; oxidative stress; energy metabolism; heart failure;
D O I
10.1016/j.ghir.2007.11.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Several evidences point for beneficial effects of growth hormone (GH) in heart failure (HF). Taking into account that HF is related with changes in myocardial oxidative stress and in energy generation from metabolic pathways, it is important to clarify whether GH increase or decrease myocardial oxidative stress and what is its effect on energetic metabolism in HF condition. Thus, this study investigated the effects of two different doses of GH on energetic metabolism and oxidative stress in myocardium of rats with HF. Male Wistar rats (n = 25) were submitted to aortic stenosis (AS). The HF was evidenced by tachypnea and echocardiographic criteria around 28 weeks of AS. The rats were then randomly divided into three groups: (HF) with HF, treated with saline (0.9% NaCl); (HF-GHI), treated with 1 mk/kg/day recombinant human growth hormone (rhGH), and (HF-GH2) treated with 2 mg/kg/day rhGH. GH was injected, subcutaneously, daily for 2 weeks. A control group (sham; n = 12), with the same age of the others rats was evaluated to confirm data for AS. HF had lower IGF-I (insulin-like growth factor-I) than sham-operated rats, and both GH treatments normalized IGF-I level. HF-GH1 animals had lower lipid hydroperoxide (LH), LH/total antioxidant substances (TAS) and glutathione-reductase than HF. Glutathione peroxidase (GSH-Px), hydroxyacyl coenzyme-A dehydrogenase, lactate dehydrogenase(LDH) were higher in HF-GH1 than in HF. HF-GH2 compared with HF, had increased LH/TAS ratio, as well as decreased oxidized glutathione and LDH activity. Comparing the two GH doses, GSH-Px, superoxide dismutase and LDH were lower in HF-GH2 than in HF-GHI. In conclusion, GH effects were dose-dependent and both tested doses did not aggravate the heart dysfunction. The higher GH dose, 2 mg/kg exerted detrimental effects related to energy metabolism and oxidative stress. The lower dose, 1 mg/kg GH exerted beneficial effects enhancing antioxidant defences, reducing oxidative stress and improving energy generation in myocardium of rats with heart failure. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:275 / 283
页数:9
相关论文
共 63 条
[1]  
Aebi H., 1974, METHODS ENZYMATIC AN
[2]   Acquired growth hormone resistance in patients with chronic heart failure: Implications for therapy with growth hormone [J].
Anker, SD ;
Volterrani, M ;
Pflaum, CD ;
Strasburger, CJ ;
Osterziel, KJ ;
Doehner, W ;
Ranke, MB ;
Poole-Wilson, PA ;
Giustina, A ;
Dietz, R ;
Coats, AJS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (02) :443-452
[3]   METABOLIC DIFFERENTIATION OF DISTINCT MUSCLE TYPES AT LEVEL OF ENZYMATIC ORGANIZATION [J].
BASS, A ;
BRDICZKA, D ;
EYER, P ;
HOFER, S ;
PETTE, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1969, 10 (02) :198-&
[4]  
Bengtsson B.-A., 1998, Journal of Endocrinological Investigation, V21, P80
[5]   Impairment of cardiac function and bioenergetics in adult transgenic mice overexpressing the bovine growth hormone gene [J].
Bollano, E ;
Omerovic, E ;
Bohlooly-Y, M ;
Kujacic, V ;
Madhu, B ;
Törnell, J ;
Isaksson, O ;
Soussi, B ;
Schulze, W ;
Fu, MLX ;
Matejka, G ;
Waagstein, F ;
Isgaard, J .
ENDOCRINOLOGY, 2000, 141 (06) :2229-2235
[6]   Myocardial contractile dysfunction contributes to the development of heart failure in rats with aortic stenosis [J].
Bregagnollo, Edson A. ;
Zornoff, Leonardo A. M. ;
Okoshi, Katashl ;
Sugizaki, Mario ;
Mestrinel, Marco A. ;
Padovani, Carlos R. ;
Cicogna, Antonio C. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 117 (01) :109-114
[7]   Activity of GH/IGF-I axis in patients with dilated cardiomyopathy [J].
Broglio, F ;
Fubini, A ;
Morello, M ;
Arvat, E ;
Aimaretti, G ;
Gianotti, L ;
Boghen, MF ;
Deghenghi, R ;
Mangiardi, L ;
Ghigo, E .
CLINICAL ENDOCRINOLOGY, 1999, 50 (04) :417-430
[8]   Antioxidative mechanisms and plasma growth hormone levels -: Potential relationship in the aging process [J].
Brown-Borg, HM ;
Bode, AM ;
Bartke, A .
ENDOCRINE, 1999, 11 (01) :41-48
[9]   Myosin heavy chain expression and atrophy in rat skeletal muscle during transition from cardiac hypertrophy to heart failure [J].
Carvalho, RF ;
Cicogna, AC ;
Campos, GER ;
De Assis, JMF ;
Padovani, CR ;
Okoshi, MP ;
Pai-Silva, MD .
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2003, 84 (04) :201-206
[10]   Growth hormone resistance in chronic heart failure and its therapeutic implications [J].
Cicoira, M ;
Kalra, PR ;
Anker, SD .
JOURNAL OF CARDIAC FAILURE, 2003, 9 (03) :219-226